Can You Get Constipated on Mounjaro — and What Can You Do About It?

The biggest misconception: most people assume it's diarrhoea they should worry about

Search conversations about GLP-1 side effects and nausea dominates, with diarrhoea a close second. Constipation gets less attention, which means people who do experience it can feel caught off guard, wondering whether something is wrong with their treatment or whether they're in a minority. They are not. Clinical trial data for Mounjaro shows constipation affecting a substantial proportion of participants, and it sits alongside nausea and vomiting as one of the medicine's documented gastrointestinal effects.

The underlying reason makes sense once you understand how tirzepatide works. It slows the rate at which the stomach empties its contents into the small intestine, a mechanism that reduces appetite and prolongs fullness. That same slowing affects the entire digestive tract. Less urgency, longer transit time, and stools that have more time to lose moisture: the conditions for constipation are built into the medicine's mechanism. That is not a flaw; it is the physiology.

For many people, constipation is at its worst during the first few weeks on a new dose and then eases as the body settles. If you are wondering why constipation feels worse at a particular point in your treatment, the timing relative to your last dose change is usually a useful clue. More on the practical side of managing this follows below.

What you can actually do, and the simple check worth doing now

There is no single fix, but a handful of consistent habits make a real difference for most people. Hydration is the most commonly overlooked lever: reduced appetite can mean reduced fluid intake, and Mounjaro's slowing of digestion compounds the effect on fluid absorption and stool consistency. A practical check you can do in under a minute is to look at the colour of your urine first thing in the morning, pale yellow suggests adequate hydration, darker shades suggest you need more fluid across the day. It sounds basic, but prescribers at our pharmacy find it is the first thing people have stopped noticing once their eating patterns change.

Beyond fluids, consistent fibre intake helps, but there is a sequencing point worth knowing: adding large amounts of fibre quickly without enough water can make constipation worse rather than better. Gradual increases, alongside adequate hydration, are more useful. Gentle movement (walking, light stretching) supports gut motility without any requirement for intense exercise.

Over-the-counter options such as osmotic laxatives are used by some people on GLP-1 medicines, but whether these are appropriate for you depends on your full health picture. That conversation belongs with your prescriber or pharmacist, not a forum thread. Our clinical team reviews this kind of question as part of ongoing aftercare, it is exactly the sort of detail that matters in a supervised programme.

A broader look at the full GI profile of Mounjaro, including the other effects that tend to appear alongside constipation, is covered on our Mounjaro side effects page.

When constipation stops being manageable: signs that need prompt attention

Most constipation on Mounjaro is uncomfortable but not dangerous. There are, however, symptoms that should not be managed at home. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines specifically flagged acute pancreatitis as an infrequent but serious risk: the warning symptom is severe stomach pain that does not ease, particularly if it radiates toward the back, with or without vomiting. This is not what ordinary constipation feels like, but people can sometimes mistake the early stages, or delay seeking help because they assume the pain is digestive in the routine sense.

Seek urgent medical attention if you experience severe or persistent abdominal pain that is different from your usual pattern, signs of significant dehydration (very dark urine, dizziness, not passing urine for long periods), or any rectal bleeding. These are not expected effects of Mounjaro and need clinical assessment promptly. The MHRA Drug Safety Updates page holds the full January 2026 communication if you or your prescriber wants to review it.

If you have had pancreatitis before, or certain other gastrointestinal conditions, your prescriber will have considered this at the point of assessment. If your circumstances have changed since your last review, contact your prescribing service, or reach us through our support line, available seven days a week.

For context on a different but related GI side effect, our page on sulphur burps and diarrhoea covers how those symptoms tend to sit alongside constipation at different phases of treatment.

Starting or continuing Mounjaro: how prescribers approach this

Constipation alone is rarely a reason to stop Mounjaro, but it is worth discussing openly with whoever prescribes for you. Managing it well means the rest of the treatment programme stays on track. At a regulated weight management service, dose increases happen once clinical suitability is confirmed (not automatically) which gives your prescriber a natural checkpoint to check in on side effects including GI ones.

If you are considering starting tirzepatide and side effects are one of your concerns, that is a legitimate question to bring to a consultation. Our prescribers discuss suitability and side effects in detail as part of the initial assessment, not as a formality, but because how you are likely to experience the medicine matters to the clinical picture. You can read more about what Mounjaro is and how it works on our Mounjaro treatment page, and if you have questions about the process, our FAQs cover the most common ones. When you are ready, speak to our prescribers as part of a free consultation.